Aim: The determined stage of ischemia and unknown HF in critical CVD events well-defined the higher incidence of SCD risk factors in the long-term modes of responsiveness with reduced LVEF if the idiopathic fibrillation lacking is not treated with counseling of LV remodeling in the association of rehospitalization survival rates.
Introduction
Sudden death in 100,000 population every year claims the mode of disastrous progression of unrecognized cardiac arrest carrying the entities of increased pathophysiological symptomatic events in the predominance of heart failure and ischemic cardiomyopathies. The modulation of multifactorial pathogenesis in the concerns of coronary artery spasm risk factors highlights the contribution of ejection fraction, atrial fibrillation, ventricular fibrillation, myocardial infarction and coronary heart disease mortality rate, the cause of origin in detecting the natural history and ECG interpretation [1] . Several cohort studies presume the disrupted arrhythmogenesis morphology by the adjacent confounding data of premature ventricular beats in provoking the therapeutic justifications of differential diagnosis based protocols at early repolarization (ER), ion channels vulnerability, hormonal perception, hypertrophy dilations or metabolic causes.
Moreover, the optimal mandatory therapy in the improvements of necessitating appropriate prophylactic emphasizes the cardiac screening of implantable cardiac device and secondary prevention [2, 3] in the resuscitation of daily diagnostic practice. The guidelines in the possible prognosis of sophisticated technology in left ventricular dysfunction incidence overlap the long-term effectiveness by the follow-up of safest tool in survival rates to analyze the comprehensive abnormalities to measure QTc interval at 12 lead ECG by the selection of angiography flow chart for the casual studies of the functional acquisition of ventricular dysplasia and artery stenosis reoccurrences.
The objective of this study is to assess the clinical experience based on the documentation of linked family history abnormalities, biomarker yields, radiography examination, routine testing and the aborted VF conceals [4] the critical controversies of predictable outcomes by reversal left ventricular remodeling in terms of revascularization to discordance the validation of benefitting responsive survivors
Methods of study patients
The study design in the randomized study of clinical effectiveness at the decompensation of Acute Heart Failure cases enrolled the participants of 3000 patients rehospitalized on worsening conditions with EF> 35%, <35%, NYHA functional class I -IV, from 2015 -2017 preserved the setting of quantified LVH by conventional viewing the end-diastolic volumes.
 Carry the limitations of drugs study composite to mortality rate. 
End points
The independent sustainable premature ventricular beats define the unexplained SCD in the witnesses of favorable stable conditions of patients  The instantaneous pre-existing pumping failure obviously makes etiology of co-morbidity progression.
 The deterioration signs and symptoms in acute heart failure nonresponders herald the predictor of quality of life abruptly requiring the rate and rhythm control within first 24 hours of admission [5, 6] .
 The classification of CVD events alike per year follow-up measures the clinical status of resuscitation therapy in the observations of life-threatening arrhythmia dysfunction episodes.
 The composite clinical score (CCS) in the improvement of each NYHA classes ≥ 25% end points preplanned the awareness of re-hospitalization treatment defining the statistical medical records sub clinically by the baseline criteria in the prolongation of blinded cardiac arrest time period at multivariable all-cause mortality.
Statistics
In the expressed standard ± deviation (SD) count the comparative parameters of dilated cardiomyopathy analysis between EF percentage distributed the transformed statistic of death ratio and re-hospitalized analysis. The impetrating multiple variables choose the assessment of survival curves in all the (n-value) responders in remodeling the impact on cardiac events. The incidence of SCD logarithm the index ratio of 0.5 equal to the proportions of <0.1 censor the evaluation of graph risk factors in the exploratory hazard proportion adjustments [7] . HR 13.5 (9.7-17.1)
The known stratifies results stepwise correlate the curve of cause based on side effects in the elimination of probability score [8] in adding the inclusion of linear co-ordinate assumption within study duration years, as measured by Kaplan-Meier. The examined caliber of each variable categorical the distribution of survival rate at the intra-observation of cardiac echocardiography of randomized calculated average value of significance in the measure of differences by using SPSS statistic version 21 (NY, USA)
Results
During the population-based follow-up of 2 years, longitudinal study divided into 2 groups 1. Rehospitalized survival rate of >1 year.
2. The HF hospitalized all-cause mortality.
A total of 3000 patients with often comorbidity of NYHA II-IV alive 70% and SCD 72% as shown in Table . 1 the incidence of EF>30% decrease the HR 0.96 (0.94 -1.00). Moreover, the overall mortality rate 1.65 (1.60 -1.69) with P<0.0001experience the equal gender effect of idiopathic ventricular fibrillation in the demonstration of 1-year hospitalization composite to the history of co-existing conditions between (55-75%) predominant risk value.
a). Baseline variables prediction for SCD:
The countless demographic data in Table 2 outline the selection of High-Quality Life and Low-Quality Life survey independent to P<0.0001. The distinguishable of previous data i.e. SBP, DBP, BMI, and NT-proBNP reveal the calculation of (35-49%) from ECG variables according to each ∆QTc interval respectively. The recognized outcome 
Discussion
The true assumption of the quarter percentage of HF in total death remains vigilance in delaying the electrical activity of LV end-diastolic recovery of evolutionary ventricular contractions [9] . The displaying risk factor of systemic arterial hypertension is a global proceeding disability in LV relaxation classifying the magnitude of HF refractory forms. The averting pathway of CHF in the dominance of LVD strictly ponder the Framingham Heart Study enormously scaffolds the rheumatic heart disease association strengthening the elliptically shaped modeling.
The triggering hemodynamic circulation optimizes the compensatory adaptation of cellular tissue study that distorts the chamber for reperfusion in the presence of aneurysm process [10] . Therefore, the prevalence of thrombusembolism engages a biological inhibitory action in co-morbidities directing the use of anticoagulation in fixed myocardial injury mass formation [11] [12] [13] .
According to recent ASCEND-HF and VARIANT studies on wider QRS complex strongly predict 30-70% HF in sustainable NSTEMI ratio of combined ischemic cardiomyopathies in common risk. And also the registry from ARISTOTLE varying ROCKET-AF and ENGAGE-AF evaluated the hazard ratio of cluster formations in the contemporary random trials differentiating the prosthetic repair reminding the long-term asymptomatic activations.
The amplifying unequivocal mechanism affects the atria fibrillation intersection in a moderate appearance of arterial disorders involvements relates the aggressiveness of low EF against mediated pump failure. As demonstrated in Figure 2 the novel finding of pivotal responder's recipient the episodes of the premature beat in the protective support of Insync ICD Italian study [14] in ascertains of necessary odd preventions. The consistent NYHA risk factor surprisingly remarks a change with an interaction of Quality of Life partially [15] in the conduction of biventricular pacing method of repolarization [16] . The hypothesis in the attachment of (REVERSE) study govern the grades of intuitive nonsurvivors [17] to measure the chronic AF within 3-6months of diagnostic review.
Moreover, the result in the diagnosis of two dimensional Trans echocardiography effectively influenced the surrogate markers of HF in the importance of stand by death cause. Furthermore, studies of RALES, MERIT, and CIBIS strike the reduction of 25-30% CHF mortality by introducing the evidence of beta blockers [18, 19] 
Clinical implications
The characteristic of VT/VF in a closer element of SCD reduced the events by restoring the medication of ACE or ARB (28) β blocker (29) and receptor antagonists (30) to overlook the further HF exacerbations at rehospitalized assumed coagulation patients. But the likelihood of survival improvement stays extensive if the use of VT ablation remains a standard goal beyond 90 days treatment of drugs it shall remain fundamental to some limit within 30-60 days that can uncertainly cause 18-20% mortality if not triage the abnormal findings concomitantly.
Limitations
The prospective considerations in the direction of tachycardia briefly fulfill the strict ECG monitoring to determine 
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